Caxton Associates (New York)’s ZELTIQ Aesthetics, Inc. ZLTQ Stock Holding History

Caxton Associates (New York)’s Portfolio ZLTQ Stock Details ZLTQ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-4,900	Closed	-$272K	–	614
2017 Q1	$272K	Buy	+4,900	New	+$246K	﹤0.01%	360

Other funds holding ZLTQ

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Caxton Associates (New York)'s ZLTQ Position: Q2 2017 in Review

Caxton Associates (New York) sold out of ZELTIQ Aesthetics, Inc. (ZLTQ) in Q2 2017, closing a stake of 4,900 shares — an estimated $272K sold.

Caxton Associates (New York) first reported a position in ZLTQ in Q1 2017 and held it in 1 quarter. The position peaked at $272K in Q1 2017. 2 funds tracked by Wall St. Rank hold ZLTQ as of Q2 2017.

Caxton Associates (New York) reported no remaining ZELTIQ Aesthetics, Inc. position as of Q2 2017 after selling out during the quarter.
Caxton Associates (New York) sold 4,900 ZELTIQ Aesthetics, Inc. shares in Q2 2017, an estimated $272K.
Caxton Associates (New York) first reported a position in ZELTIQ Aesthetics, Inc. in Q1 2017 and held it in 1 quarter.
Caxton Associates (New York)'s ZELTIQ Aesthetics, Inc. position peaked at $272K in Q1 2017.
2 funds tracked by Wall St. Rank held ZELTIQ Aesthetics, Inc. as of Q2 2017.

Based on Caxton Associates (New York)'s 13F filing for Q2 2017, filed 14 Aug 2017.